Inside Edition
@InsideEdition·13.8M subscribers·37K videos
FDA Approves Promising Drug to Treat Alzheimer’s Disease
Posted
July 7, 2023
Views
23,634
Likes
628
Comments
64
Engagement
2.93%
July 7, 2023
23,634
628
64
2.93%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:19Now PlayingAlzheimer’s patients are praising the FDA’s approval of a groundbreaking drug that scientists say has shown to delay symptoms of the disease. Susie Mitchell tells CBS News she’s experienced promising results using Leqembi. The drug reduces amyloid beta plaque in the brain, according to the FDA, which is a marker for Alzheimer’s. Mitchell’s husband says he hasn’t seen her symptoms worsening. Inside Edition Digital’s Mara Montalbano has more.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
